Identification of 12p as a region of frequent deletion in advanced prostate cancer

Cancer Research

Volumn 58, Issue 24, 1998, Pages 5652-5655

  Kibel, Adam S ^a,c   Schutte, Mieke ^b   Kern, Scott E ^a   Isaacs, William B ^a   Steven Bova, G ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b ERASMUS MC CANCER INSTITUTE   (Netherlands)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADVANCED CANCER; ARTICLE; CARCINOGENESIS; CHROMOSOME 12P; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE DELETION; GENE MAPPING; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANIMALS; BLOTTING, SOUTHERN; BONE NEOPLASMS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICE; MICE, SCID; MIDDLE AGED; NEOPLASM TRANSPLANTATION; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; SEQUENCE DELETION;

EID: 0032535003     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bova, G. S., Carter, B. S., Bussemakers, M. J., Emi,.M., Fujiwarra, Y., Kyprianou, N., Jacobs, S. C., Robinson, J. C, Epstein, J. I., Walsh, P. C., and Isaacs, W. B. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res., 53: 3869-3873, 1993.
2. Carter, B. S., Ewing, C. M., Ward, W. S., Treiger, B. R, Aalders, T. W., Schalken, J. A., Epstein, J. I., and Isaacs, W. B. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc. Natl. Acad. Sci. USA, 87: 8751-8755, 1990.
3. Sakr, W. A., Macoska, J. A., Benson, P., Grignon, D. J., Wolman, S. R., Pontes, J. E., and Crissman, J. D. Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res., 54: 3273-3277, 1994.
4. Kunimi, K., Bergerheim, U. S., Larsson, I. L., Ekman, P., and Collins, V. P. Allelotyping of human prostatic adenocarcinoma. Genomics, 11: 530-536, 1991.
5. Cher, M. L., Bova, G. S., Moore, D. H., Small, E. J., Carroll, P. R., Pin, S. S., Epstein, J. I., Isaacs, W. B., and Jensen, R. H. Genetic alterations in untreated prostate cancer metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res., 56: 3091-3102, 1996.
6. Visakorpi, T., Kallioniemi, A., Syvanen, A. C., Hyytinen, E. R., Karhu, R., Tammela, T., Isola, J. J., and Kallioniemi, O. P. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res., 55: 342-347, 1995.
7. Bova, G. S., and Isaacs, W. B. Review of allelic loss and gain in prostate cancer. World J. Urol., 14: 338-346, 1996.
8. Marshall, C. T. Tumor suppressor genes. Cell, 64: 313-326, 1991.
9. Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., and Dryja, T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (Lend.), 323: 643-646, 1986.
10. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H., and Parsons, R., PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Washington DC), 275: 1943-1947, 1997.
11. Morion, R. A., Ewing, C. M., Nagafuchi, A., Tsukita, S., and Isaacs, W. B. Reduction of E-cadherin levels, and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res., 53: 3585-3590, 1993.
12. Paul, R., Ewing, C. M., Jarrard, D. F., and Isaacs, W. B. The cadherin cell-cell adhesion pathway in prostate cancer progression. Br. J. Urol., 79 (Suppl. 1): 37-43, 1997.
13. Suzuki, H., Freije, D., Nusskern, D. R., Okami, K., Cairns, P., Sidransky, D., Isaacs, W. B., and Bova, G. S. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res., 58: 204-209, 1998.
14. Bookstein, R., Bova, G. S., MacGrogan, D., Levy, A., and Isaacs, W. B. Tumour-suppressor genes in prostatic oncogenesis: a positional approach. Br. J. Urol., 79 (Suppl. 1).- 28-36, 1997.
15. Lisitsyn, N., Lisitsyn, N., and Wigler, M. Cloning the differences between two complex genomes. Science (Washington DC), 259: 946-951, 1993.
16. Schutte, M., da Costa, L. T., Hahn, S. A., Moskaluk, C., Hoque, A. T., Rozenblum, E., Weinstein, C. L., Bittner, M., Meltzer, P. S., Trent, J. M., Yeo, C. J., Hruban, R. H., and Kern, S. E. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc. Natl. Acad. Sci. USA, 92: 5950-5954, 1995.
17. McCombie, W. R., Heiner, C., Kelly, J. M., Fitzgerald, M. G., and Gocayne, J. D. Rapid and reliable fluorescent cycle sequencing of double stranded templates. DNA Seq., 2: 289-296, 1992.
18. Dib, C., Faure, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., Lathrop, M., Gyapay, G., Morissette, J., and Weissenbach, J. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (Lond.), 380: 152-154, 1996.
19. Beruhe, N. G., Speevak, M. D., and Chevrette, M. Suppression of tumorigenicity of human prostate cancer cells by introduction of human chromosome del(12)(q13). Cancer Res., 54: 3077-3081, 1994.
20. Sato, T., Saito, H., Morita, R., Koi, S., Lee, J. H., and Nakamura, Y. Allelotype of human ovarian cancer. Cancer Res., 51: 5118-5122, 1991.
21. Baccichet, A., and Sinnett, D. Frequent deletion of chromosome 12p12.3 in children with acute lymphoblastic leukaemia. Br. J. Haematol., 99: 107-114, 1997.
22. Takeuchi, S., Mori, N., Koike, M., Slater, J., Park, S., Miller, C. W., Miyoshi, I., and Koeffler, H. P. Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12. Cancer Res., 56: 738-740, 1996.